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Since the publication of a joint International Programme on Chemical Safety 
report in 2002 assessing the scientific knowledge of endocrine disruptors, there 
has been a dramatic increase in both awareness of the risk they may pose and 
studies of potential health implications for humans and wildlife (1). Of all the 
endocrine disruptors studied to date, there has been considerable focus on 
bisphenol A (BPA), in particular on its effects on the reproductive axis (2). BPA is 
a widely used industrial chemical which has been found in 95% of urine samples 
from adults the United States (3), with contaminated food and water accounting 
for 90% of exposure (4). Whilst most studies have focused on the estrogenic 
activity of BPA, it has also been shown to bind to androgen and thyroid hormone 
receptors, suggesting that it may disrupt multiple endocrine systems. In the 
reproductive axis, BPA has been reported to adversely affect several end points 
of fertility, advance puberty and induce polycystic ovarian syndrome (2).  
 
In this edition of Endocrinology, Eckstrum and colleagues (5) describe effects of 
BPA on gonadotrophs during an important pituitary developmental window in 
neonatal mice. The authors have found that the gene encoding intracellular 
adhesion molecule-5 (Icam5; also known as telencephalin) is more highly 
expressed in the pituitary of day-old female mice compared with their male 
littermates. They go on to show that the RNA and protein is predominantly 
expressed in gonadotrophs, with increased expression during the early postnatal 
period (up to day 20), with a continued higher expression in females than males. 
The disrupting effect of BPA on this expression is demonstrated in females and 
males in ex vivo cultures, and in females in vivo, with lower expression of Icam5. 
This work builds on previous studies describing effects on BPA exposure in utero 
by the same group, where different effects on the reproductive axis were 
described, consistent with the concept that specific windows of the development 
of endocrine axes may be differentially affected by the same endocrine disruptor.  
 
What is the potential role of Icam5 in normal pituitary function? Expression of 
this gene has previously been considered to occur only in the telencephalon, 
where it has a role in the regulation of the interactions between axonal 
protrusions and dendritic spines which form neuronal synapses. Loss of Icam5 in 
knockout mice leads to a reduction in filopodia which develop into dendritic 
spines (6) and increased spinal maturation, overexpression the reverse. This 
kind of cell-cell interaction leading to functional connectivity has been described 
in the pituitary, where homotypic cell networks have been shown to exist, with 
important roles in the regulation of cell function at both the level of secretion (7) 
and gene expression (8). The proteins regulating this cell network formation 
have not been identified but those with a function similar to that described for 
ICAM5 are likely to be mediators, making it a likely candidate. In the neonate, it 
is possible that ICAM5 mediates the formation of the gonadotroph network 
described by Budry and colleagues (9). This network begins its development 
before birth and it would be interesting to determine whether there is a window 
of Icam5 expression in these early gonadotrophs. In the adult, ICAM5 was only 
found in a subset of gonadotrophs- what could be its role at this time? There is 
considerable plasticity in the organisation of pituitary cell networks, dependent 
on physiological status and we would suggest that Icam5 may have a role in 
reorganisation of the gonadotroph network. Interestingly, gonadotroph 
protrusions, similar to the filopodia described in telencephalic neurons, have 
been described in adult female mice, with a potential role in remodelling the 
relationship of the gonadotroph network with the vasculature (10).  Again, there 
is clear potential for a role for Icam5 in mediating this remodelling. 
 
What are the potential consequences of disrupting Icam5? Loss of Icam5 may be 
expected to lead to disruption of normal reproductive function through a failure 
of normal gonadotroph network formation, with potential alteration of secretory 
and gene transcriptional responses to GnRH. There are no reports in the 
literature of a reproductive phenotype in mice with a loss of functional ICAM5 
but it is possible that subtle effects, such as altered vaginal opening or disrupted 
estrous cycles may not have been noted, especially in studies where the purpose 
of generating the knockout mouse was focused on other expected phenotypes. A 
reduced expression of Icam5 following neonatal exposure to BPA may be 
expected to have a similar effect. It should be noted that, whilst there is 
controversy over the levels of exposure of BPA that may cause endocrine 
disruption, the doses affecting Icam5 expression in ex vivo cultures in the study 
of Eckstrum and colleagues (5) are only 10 fold higher than  the US 
Environmental Protection Agency estimates of a safe dose for oral exposure.  
 
It is clear that further studies of the role of Icam5 in normal pituitary function 
are warranted. In particular, it would be interesting to determine whether the 
reduction in Icam5 resulting from neonatal exposure to BPA, or from loss of 
functional ICAM5, translates into an altered function of the adult gland and an 
impact on reproductive function through disrupted gonadotroph networks. This 
would have implications for a potential impact of endocrine disruptors on other 
pituitary networks, with far-reaching consequences for physiological regulation 
and health. 
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